NUVB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.07%

Insider Buying (Last 12 Months): $1,985,500.47

Insider Selling (Last 12 Months): $0.00

Nuvation Bio Insider Trading History Chart

Nuvation Bio Share Price & Price History

^$2.68

▼ -0.01 (-0.37%)

As of 12/20/2024 06:31 PM ET

Days: 30 | 90 | 365

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong

From Brownstone Research | Ad

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.

Nuvation Bio Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/8/2024	Robert Mashal	Director	Buy	100,000	$2.20	$220,000.00	100,000
6/24/2024	Xiangmin Cui	Director	Buy	336,874	$2.98	$1,003,884.52	2,175,236
6/20/2024	Xiangmin Cui	Director	Buy	87,715	$2.99	$262,267.85	1,762,951
6/11/2024	Kim D Blickenstaff	Director	Buy	172,189	$2.90	$499,348.10	172,189
2/21/2023	Oleg Nodelman	Director	Buy	53,000	$1.36	$72,080.00	12,674,775
2/19/2023	Oleg Nodelman	Director	Buy	5,143,000	$1.26	$6,480,180.00	12,504,675
12/5/2022	Kathryn E Falberg	Director	Buy	43,000	$1.95	$83,850.00	250,000
12/2/2022	Kathryn E Falberg	Director	Buy	47,000	$1.98	$93,060.00	207,000
11/30/2022	Kathryn E Falberg	Director	Buy	75,041	$1.85	$138,825.85	75,041
4/5/2022	Fund V L.P. Omega	Major Shareholder	Sell	2,500,000	$5.60	$14,000,000.00	20,457,340

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong

From Brownstone Research | Ad

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.

SEC Filings (Institutional Ownership Changes) for Nuvation Bio (NYSE:NUVB)

61.67% of Nuvation Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Nuvation Bio Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/19/2024	Principal Financial Group Inc.	12,502	$29K	0.0%	-51.8%	0.004%
11/16/2024	Geode Capital Management LLC	4,028,692	$9.23M	0.0%	+5.1%	1.616%
11/15/2024	Frazier Life Sciences Management L.P.	1,218,236	$2.79M	0.1%	N/A	0.489%
11/15/2024	XTX Topco Ltd	132,029	$0.30M	0.0%	N/A	0.053%
11/15/2024	Zacks Investment Management	36,125	$83K	0.0%	+21.5%	0.014%
11/15/2024	Jane Street Group LLC	84,039	$0.19M	0.0%	-71.7%	0.034%
11/15/2024	Wellington Management Group LLP	623,973	$1.43M	0.0%	+83.3%	0.250%
11/15/2024	Wexford Capital LP	651,767	$1.49M	0.4%	+930.2%	0.261%
11/15/2024	State Street Corp	4,166,441	$9.54M	0.0%	+4.8%	1.672%
11/15/2024	Point72 Asset Management L.P.	276,714	$0.63M	0.0%	N/A	0.111%
11/15/2024	Ikarian Capital LLC	83,282	$0.19M	0.0%	-76.8%	0.033%
11/14/2024	Verition Fund Management LLC	13,375	$31K	0.0%	-50.1%	0.005%
11/14/2024	Walleye Capital LLC	195,131	$0.45M	0.0%	+97.2%	0.078%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	225,619	$0.52M	0.0%	-3.7%	0.091%
11/14/2024	MetLife Investment Management LLC	91,051	$0.21M	0.0%	-13.8%	0.037%
11/13/2024	Quantbot Technologies LP	72,226	$0.17M	0.0%	N/A	0.029%
11/13/2024	FMR LLC	29,238,871	$66.96M	0.0%	+1.4%	11.731%
11/12/2024	Algert Global LLC	288,189	$0.66M	0.0%	-32.4%	0.116%
11/12/2024	Meridian Wealth Management LLC	82,840	$0.19M	0.0%	+47.0%	0.033%
11/12/2024	Charles Schwab Investment Management Inc.	1,394,015	$3.19M	0.0%	+4.5%	0.559%
11/9/2024	Intech Investment Management LLC	57,856	$0.13M	0.0%	N/A	0.023%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	396,736	$0.91M	0.0%	+9.0%	0.159%
11/6/2024	Cornercap Investment Counsel Inc.	25,811	$59K	0.0%	-53.5%	0.010%
11/5/2024	GSA Capital Partners LLP	74,932	$0.17M	0.0%	N/A	0.030%
10/31/2024	Principal Financial Group Inc.	12,502	$29K	0.0%	-51.8%	0.005%
10/28/2024	Palumbo Wealth Management LLC	16,446	$38K	0.0%	-42.0%	0.007%
10/23/2024	Assenagon Asset Management S.A.	438,539	$1M	0.0%	-23.7%	0.176%
10/11/2024	Creative Planning	12,640	$29K	0.0%	-43.0%	0.005%
10/10/2024	Exchange Traded Concepts LLC	54,548	$0.13M	0.0%	-45.0%	0.022%
10/8/2024	Marquette Asset Management LLC	56,114	$0.13M	0.0%	-15.0%	0.023%
10/3/2024	SG Americas Securities LLC	72,057	$0.17M	0.0%	+125.8%	0.029%
8/19/2024	B. Riley Wealth Advisors Inc.	10,000	$29K	0.0%	N/A	0.004%
8/16/2024	Algert Global LLC	426,603	$1.25M	0.0%	+281.0%	0.171%
8/15/2024	Susquehanna Fundamental Investments LLC	76,494	$0.22M	0.0%	+252.0%	0.031%
8/15/2024	The Manufacturers Life Insurance Company	70,963	$0.21M	0.0%	-43.4%	0.028%
8/15/2024	AQR Capital Management LLC	111,583	$0.33M	0.0%	+508.1%	0.045%
8/15/2024	Caxton Associates LP	14,558	$43K	0.0%	N/A	0.006%
8/14/2024	Xponance Inc.	11,351	$33K	0.0%	N/A	0.005%
8/14/2024	EverSource Wealth Advisors LLC	11,095	$32K	0.0%	+913.2%	0.004%
8/14/2024	ProShare Advisors LLC	19,513	$57K	0.0%	-25.4%	0.008%
8/14/2024	Profund Advisors LLC	21,720	$63K	0.0%	N/A	0.009%
8/13/2024	Public Employees Retirement Association of Colorado	29,841	$87K	0.0%	-17.8%	0.012%
8/12/2024	Hsbc Holdings PLC	133,308	$0.43M	0.0%	-30.4%	0.054%
8/9/2024	Renaissance Technologies LLC	761,000	$2.22M	0.0%	-21.9%	0.308%
8/9/2024	Dimensional Fund Advisors LP	1,018,329	$2.98M	0.0%	+415.2%	0.412%
8/9/2024	WINTON GROUP Ltd	30,350	$89K	0.0%	N/A	0.012%
8/8/2024	Cornercap Investment Counsel Inc.	55,509	$0.16M	0.0%	-53.0%	0.022%
8/8/2024	American Century Companies Inc.	243,358	$0.71M	0.0%	+120.4%	0.098%
8/7/2024	Choreo LLC	14,811	$47K	0.0%	N/A	0.006%
8/6/2024	Acadian Asset Management LLC	653,184	$1.91M	0.0%	-44.4%	0.264%
8/5/2024	Acuitas Investments LLC	365,741	$1.07M	0.6%	-31.9%	0.148%
8/5/2024	Arizona State Retirement System	37,829	$0.11M	0.0%	N/A	0.015%
8/1/2024	Rhumbline Advisers	260,939	$0.76M	0.0%	+25.7%	0.106%
7/29/2024	Principal Financial Group Inc.	25,950	$76K	0.0%	+58.7%	0.010%
7/29/2024	Panagora Asset Management Inc.	633,676	$1.85M	0.0%	+198.7%	0.256%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	43,050	$0.13M	0.0%	N/A	0.017%
7/26/2024	Bank of New York Mellon Corp	626,905	$1.83M	0.0%	+33.6%	0.254%
7/12/2024	SG Americas Securities LLC	31,916	$93K	0.0%	-37.0%	0.013%
5/17/2024	Ikarian Capital LLC	633,282	$2.31M	0.3%	-48.2%	0.290%
5/16/2024	California State Teachers Retirement System	14,646	$53K	0.0%	-38.9%	0.007%
5/16/2024	Jacobs Levy Equity Management Inc.	748,793	$2.73M	0.0%	+254.1%	0.343%
5/15/2024	Public Employees Retirement System of Ohio	114,946	$0.42M	0.0%	+645.5%	0.053%
5/15/2024	Price T Rowe Associates Inc. MD	1,354,632	$4.93M	0.0%	+551.8%	0.621%
5/10/2024	Acadian Asset Management LLC	1,174,464	$4.27M	0.0%	+81.9%	0.539%
5/10/2024	Vanguard Group Inc.	7,534,148	$27.42M	0.0%	+3.0%	3.455%
5/10/2024	Pinnacle Wealth Planning Services Inc.	28,761	$0.11M	0.0%	N/A	0.013%
5/8/2024	Russell Investments Group Ltd.	33,579	$0.12M	0.0%	-11.8%	0.015%
5/7/2024	Susquehanna Fundamental Investments LLC	21,732	$79K	0.0%	N/A	0.010%
5/7/2024	SG Americas Securities LLC	50,626	$0.18M	0.0%	-36.4%	0.023%
5/7/2024	Marquette Asset Management LLC	97,741	$0.36M	0.1%	-12.5%	0.045%
4/24/2024	Assenagon Asset Management S.A.	574,410	$2.09M	0.0%	-22.3%	0.263%
2/15/2024	Octagon Capital Advisors LP	1,000,000	$1.51M	0.2%	N/A	0.457%
2/8/2024	Beacon Pointe Advisors LLC	21,700	$33K	0.0%	N/A	0.010%
2/7/2024	Gladius Capital Management LP	30,967	$47K	0.0%	+92.6%	0.014%
2/5/2024	Intellectus Partners LLC	181,122	$0.27M	0.1%	-15.4%	0.083%
2/2/2024	Marquette Asset Management LLC	111,759	$0.17M	0.0%	+70.9%	0.051%
2/2/2024	Acuitas Investments LLC	460,471	$0.66M	0.3%	+45.5%	0.210%
1/31/2024	Federated Hermes Inc.	359,671	$0.54M	0.0%	-2.1%	0.164%
1/17/2024	Assenagon Asset Management S.A.	738,831	$1.12M	0.0%	+219.3%	0.337%
1/12/2024	SG Americas Securities LLC	79,604	$0.12M	0.0%	-27.8%	0.036%
1/5/2024	Exchange Traded Concepts LLC	107,843	$0.16M	0.0%	+34.0%	0.049%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	276,174	$0.37M	0.0%	+69.1%	0.126%
11/13/2023	Acadian Asset Management LLC	113,717	$0.15M	0.0%	+258.9%	0.052%
11/13/2023	Hsbc Holdings PLC	174,827	$0.24M	0.0%	+56.1%	0.080%
11/13/2023	FMR LLC	32,684,916	$43.80M	0.0%	+0.0%	14.929%
11/8/2023	New York Life Investment Management LLC	214,484	$0.29M	0.0%	-13.6%	0.098%
11/6/2023	Assenagon Asset Management S.A.	231,379	$0.31M	0.0%	-15.5%	0.106%
10/27/2023	TD Asset Management Inc	105,600	$0.14M	0.0%	+100.0%	0.048%
10/19/2023	Clarius Group LLC	19,691	$26K	0.0%	N/A	0.009%
10/13/2023	SG Americas Securities LLC	110,226	$0.15M	0.0%	+921.4%	0.050%
8/14/2023	Wexford Capital LP	25,700	$46K	0.0%	-73.7%	0.012%
8/14/2023	Prosight Management LP	1,100,000	$1.98M	0.6%	N/A	0.502%
8/14/2023	Prelude Capital Management LLC	65,504	$0.12M	0.0%	-11.2%	0.030%
8/11/2023	AWM Investment Company Inc.	1,425,000	$2.57M	0.3%	-6.6%	0.651%
8/7/2023	Principal Financial Group Inc.	15,468	$28K	0.0%	-68.2%	0.007%
8/7/2023	Acadian Asset Management LLC	31,686	$57K	0.0%	N/A	0.014%
8/7/2023	New York Life Investment Management LLC	248,274	$0.45M	0.0%	-12.8%	0.113%
8/4/2023	American International Group Inc.	70,118	$0.13M	0.0%	+24.8%	0.032%
7/28/2023	Marquette Asset Management LLC	65,390	$0.12M	0.0%	N/A	0.030%
7/25/2023	Assenagon Asset Management S.A.	273,714	$0.49M	0.0%	-43.2%	0.125%

Data available starting January 2016

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-868, a BD2 selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation, including oncogenes comprising c-myc; NUV-1156, an AR binder Xtandi that address advanced stage prostate cancers with the potential to move into earlier lines typically treated with surgical prostatectomy; and drug-drug conjugate (DDC) platform which leverages a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies to deliver anti-cancer therapeutics to cancer cells, as well as NUV-1176, a PARP inhibitor to address ER+ breast and ovarian cancer. The company was founded in 2018 and is headquartered in New York, New York.

Today's Range

Now: $2.68

$2.57

$2.76

50 Day Range

MA: $2.62

$2.19

$3.01

52 Week Range

Now: $2.68

$1.43

$4.16

Volume

9,241,831 shs

Average Volume

1,604,938 shs

Market Capitalization

$902.00 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.46

Who are the company insiders with the largest holdings of Nuvation Bio?: Nuvation Bio's top insider shareholders include:
Oleg Nodelman (Director)
Xiangmin Cui (Director)
Kim D Blickenstaff (Director)
Robert Mashal (Director)
Learn More about top insider investors at Nuvation Bio.
Who are the major institutional investors of Nuvation Bio?: Nuvation Bio's top institutional shareholders include:
FMR LLC — 11.73%
State Street Corp — 1.67%
Geode Capital Management LLC — 1.62%
Charles Schwab Investment Management Inc. — 0.56%
Frazier Life Sciences Management L.P. — 0.49%
Wexford Capital LP — 0.26%
Learn More about top institutional investors of Nuvation Bio stock.
Which institutional investors are selling Nuvation Bio stock?: During the last quarter, NUVB stock was sold by these institutional investors:
Ikarian Capital LLC
Jane Street Group LLC
Algert Global LLC
Assenagon Asset Management S.A.
Exchange Traded Concepts LLC
Cornercap Investment Counsel Inc.
MetLife Investment Management LLC
Principal Financial Group Inc.
Which institutional investors are buying Nuvation Bio stock?: During the last quarter, NUVB stock was acquired by institutional investors including:
Frazier Life Sciences Management L.P.
Wexford Capital LP
FMR LLC
Wellington Management Group LLP
Point72 Asset Management L.P.
Geode Capital Management LLC
State Street Corp
XTX Topco Ltd
In the last year, these company insiders have bought Nuvation Bio stock:
Oleg Nodelman (Director)
Xiangmin Cui (Director)
Kim D Blickenstaff (Director)
Robert Mashal (Director)
Learn More investors buying Nuvation Bio stock.